←Back to structures
NC_027340.1__YP_009147657.1__NW77_145__00145
Bact-VirNC_027340.1__YP_009147657.1__NW77_145__00145
Identity
- Accession:
- NC_027340 ↗
- Kingdom:
- phage
Quality
77.9
mean pLDDT
Taxonomy
Heunggongvirae›
Uroviricota›
Caudoviricetes›
Pantevenvirales›
Ackermannviridae›
Nezavisimistyvirus›
Erwinia_phage_phiEa2809
TaxID: 1564096
Cluster
View cluster (4 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 5-111
Domain cluster:
rep: OK539832.1__UGL60195.1__X__00089__D10-62_80-115
CATH (56)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4r80A00 | 3.10.450.630 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.78 | 50.0 | 5.84e-01 | 99.1% | 92.1% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.75 | 51.0 | 5.59e-01 | 98.1% | 86.2% |
| 1wnhA01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 59.0 | 6.08e-01 | 100.0% | 89.0% |
| 1t17A00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.72 | 45.0 | 3.97e-01 | 92.5% | 44.6% |
| 2w4yA00 | 2.40.160.220 | Mainly Beta › Beta Barrel › Porin › | 0.68 | 41.0 | 3.95e-01 | 100.0% | 52.5% |
| 5o46A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 57.0 | 5.57e-01 | 100.0% | 87.7% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 58.0 | 5.23e-01 | 98.1% | 89.4% |
| 2cw9A00 | 3.10.450.240 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 58.0 | 4.84e-01 | 100.0% | 82.4% |
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 57.0 | 5.28e-01 | 99.1% | 89.0% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 56.0 | 5.25e-01 | 97.2% | 92.4% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 56.0 | 5.01e-01 | 98.1% | 90.5% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.62 | 46.0 | 3.94e-01 | 97.2% | 49.4% |
| 1l3aA00 | 2.30.31.10 | Mainly Beta › Roll › Transcriptional Co-activator pc4; Chain A › Transcriptional Coactivator Pc4; Chain A | 0.62 | 37.0 | 3.13e-01 | 70.1% | 38.6% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.17e-01 | 98.1% | 95.4% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.18e-01 | 98.1% | 94.5% |
| 2ch9A01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 54.0 | 5.34e-01 | 100.0% | 91.2% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 54.0 | 5.21e-01 | 97.2% | 96.7% |
| 3ejvA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 53.0 | 4.61e-01 | 94.4% | 93.7% |
| 3rgaA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 55.0 | 4.88e-01 | 98.1% | 91.2% |
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 54.0 | 5.40e-01 | 97.2% | 94.5% |
| 3f9sB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 55.0 | 4.98e-01 | 100.0% | 90.8% |
| 4rlcA00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.60 | 53.0 | 4.94e-01 | 98.1% | 85.2% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 53.0 | 4.48e-01 | 100.0% | 88.7% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 54.0 | 4.86e-01 | 100.0% | 89.6% |
| 3dmcA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 4.86e-01 | 97.2% | 88.8% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 52.0 | 4.71e-01 | 98.1% | 81.5% |
| 1sjwA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 53.0 | 4.78e-01 | 98.1% | 86.6% |
| 3j7yd00 | 3.10.450.240 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 52.0 | 4.57e-01 | 100.0% | 85.8% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 52.0 | 4.82e-01 | 97.2% | 92.5% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 52.0 | 4.89e-01 | 97.2% | 87.6% |
| 2chcC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 51.0 | 4.44e-01 | 95.3% | 75.5% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 52.0 | 4.90e-01 | 97.2% | 93.7% |
| 3f14A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 52.0 | 5.14e-01 | 98.1% | 97.3% |
| 3blzA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 51.0 | 4.90e-01 | 98.1% | 91.9% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 53.0 | 4.94e-01 | 100.0% | 86.9% |
| 3fkaB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 51.0 | 4.90e-01 | 98.1% | 93.3% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 50.0 | 4.64e-01 | 97.2% | 92.6% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 50.0 | 4.44e-01 | 98.1% | 80.5% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 50.0 | 4.78e-01 | 98.1% | 90.3% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 50.0 | 4.74e-01 | 98.1% | 90.6% |
| 2jq5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.55 | 50.0 | 4.74e-01 | 100.0% | 95.3% |
| 2rjzA02 | 3.30.70.60 | Alpha Beta › 2-Layer Sandwich › Alpha-Beta Plaits › Ribosomal protein S6/Translation elongation factor EF1B | 0.55 | 42.0 | 4.39e-01 | 81.3% | 97.0% |
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.55 | 50.0 | 4.73e-01 | 100.0% | 90.6% |
| 3pgbA01 | 2.70.98.20 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › Copper amine oxidase, catalytic domain | 0.55 | 38.0 | 2.51e-01 | 93.5% | 15.3% |
| 3ecfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.54 | 50.0 | 4.69e-01 | 99.1% | 82.8% |
| 3k7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.54 | 47.0 | 4.71e-01 | 94.4% | 98.1% |
| 3fljA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 47.0 | 4.30e-01 | 97.2% | 72.3% |
| 3f8xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 47.0 | 4.37e-01 | 97.2% | 77.3% |
| 4qa8A00 | 2.50.20.20 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.52 | 47.0 | 3.78e-01 | 100.0% | 88.1% |
| 3en8A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.52 | 47.0 | 4.67e-01 | 100.0% | 93.8% |
| 5evhA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.52 | 45.0 | 4.33e-01 | 97.2% | 84.3% |
| 1h2iA01 | 3.30.390.80 | Alpha Beta › 2-Layer Sandwich › Enolase-like; domain 1 › DNA repair protein Rad52/59/22 | 0.51 | 39.0 | 3.54e-01 | 82.2% | 58.8% |
| 2r5rA00 | 3.10.270.10 | Alpha Beta › Roll › Urate Oxidase › Urate Oxidase; | 0.51 | 46.0 | 3.55e-01 | 100.0% | 48.8% |
| 2yn5A01 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.51 | 29.0 | 3.38e-01 | 75.7% | 77.2% |
| 3mh9A00 | 2.50.20.20 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.51 | 46.0 | 3.73e-01 | 100.0% | 84.9% |
| 1cbyA00 | 3.40.198.10 | Alpha Beta › 3-Layer(aba) Sandwich › Delta-endotoxin CytB › Delta-endotoxin CytB-like | 0.50 | 40.0 | 3.19e-01 | 86.9% | 49.3% |
ECOD (62)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3636567 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 5.29e-01 | 100.0% | 78.6% |
| 3513177 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.72 | 64.0 | 6.46e-01 | 100.0% | 96.2% |
| 3227579 | 331.3.1.6 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › PRELI | 0.70 | 52.0 | 4.29e-01 | 95.3% | 45.6% |
| 3399719 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 58.0 | 5.93e-01 | 93.5% | 92.4% |
| 3263321 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 62.0 | 5.52e-01 | 98.1% | 93.8% |
| 3608271 | 2003.1.5.0 ↗ | a/b three-layered sandwiches › Rossmann-like › Rossmann-related › S-adenosyl-L-methionine-dependent methyltransferases | 0.67 | 58.0 | 4.05e-01 | 94.4% | 33.3% |
| 3890249 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.67 | 60.0 | 6.13e-01 | 100.0% | 99.0% |
| 3423924 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.67 | 58.0 | 5.61e-01 | 99.1% | 83.3% |
| 3220280 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 61.0 | 6.07e-01 | 100.0% | 97.3% |
| 3521659 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.66 | 57.0 | 5.73e-01 | 100.0% | 90.9% |
| 3425035 | 243.1.1.122 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF28340 | 0.65 | 54.0 | 5.66e-01 | 93.5% | 96.0% |
| 3858424 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.65 | 55.0 | 5.59e-01 | 100.0% | 92.4% |
| 3732472 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 59.0 | 5.03e-01 | 100.0% | 92.9% |
| 3595171 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 59.0 | 4.58e-01 | 100.0% | 89.1% |
| 4225360 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.65 | 58.0 | 5.52e-01 | 100.0% | 83.2% |
| 3895474 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.64 | 57.0 | 5.58e-01 | 100.0% | 88.7% |
| 3521640 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.64 | 57.0 | 5.55e-01 | 100.0% | 87.8% |
| 3895949 | 243.3.1.2 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cathelicidins | 0.64 | 56.0 | 5.46e-01 | 97.2% | 87.0% |
| 3181792 | 331.3.1.6 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › PRELI | 0.63 | 49.0 | 3.93e-01 | 95.3% | 43.5% |
| 3874957 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 57.0 | 5.16e-01 | 100.0% | 74.3% |
| 3559415 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.63 | 57.0 | 5.44e-01 | 100.0% | 84.8% |
| 1282324 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.63 | 57.0 | 5.35e-01 | 100.0% | 95.5% |
| 3917066 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.63 | 56.0 | 5.53e-01 | 100.0% | 90.4% |
| 3546025 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.63 | 56.0 | 5.19e-01 | 100.0% | 77.0% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.62 | 57.0 | 5.53e-01 | 100.0% | 97.5% |
| 4349674 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.62 | 53.0 | 5.13e-01 | 99.1% | 82.5% |
| 3727278 | 331.3.1.6 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › PRELI | 0.62 | 48.0 | 3.80e-01 | 95.3% | 40.9% |
| 4063721 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.61 | 55.0 | 5.26e-01 | 100.0% | 84.0% |
| 3473466 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.61 | 56.0 | 4.34e-01 | 100.0% | 87.8% |
| 3311465 | 9.3.1.4 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › DUF2921_N | 0.61 | 54.0 | 4.26e-01 | 98.1% | 79.1% |
| 3517508 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.61 | 51.0 | 5.40e-01 | 96.3% | 100.0% |
| 3749143 | 243.3.1.20 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › AKAP28 | 0.61 | 45.0 | 4.36e-01 | 96.3% | 68.0% |
| 3222760 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.61 | 52.0 | 5.40e-01 | 100.0% | 99.0% |
| 6406 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.61 | 53.0 | 4.61e-01 | 94.4% | 93.7% |
| 3843944 | 243.5.1.7 ↗ | a+b two layers › Cystatin-like › Amine oxidase N-terminal region › Amine oxidase N-terminal region › AKAP28 | 0.61 | 45.0 | 4.34e-01 | 96.3% | 68.0% |
| 3520317 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.59 | 49.0 | 5.03e-01 | 100.0% | 91.4% |
| 3510463 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.59 | 52.0 | 5.23e-01 | 100.0% | 93.6% |
| 3510502 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.59 | 49.0 | 5.20e-01 | 99.1% | 100.0% |
| 3279671 | 243.1.1.10 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL | 0.59 | 53.0 | 4.88e-01 | 97.2% | 90.4% |
| 5002369 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.59 | 54.0 | 5.27e-01 | 100.0% | 97.4% |
| 3879513 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.59 | 52.0 | 4.98e-01 | 95.3% | 84.2% |
| 3517310 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.58 | 51.0 | 5.13e-01 | 100.0% | 93.6% |
| 3996178 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.58 | 51.0 | 5.17e-01 | 95.3% | 98.1% |
| 3284100 | 243.1.1.10 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL | 0.58 | 51.0 | 4.38e-01 | 97.2% | 79.4% |
| 3486447 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.57 | 45.0 | 4.54e-01 | 84.1% | 86.7% |
| 3770861 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.56 | 51.0 | 4.54e-01 | 98.1% | 90.7% |
| 4423634 | 883.1.1.18 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › PF26545 | 0.56 | 51.0 | 4.08e-01 | 100.0% | 72.3% |
| 197096 | 310.3.1.1 ↗ | a+b two layers › RRF/tRNA synthetase additional domain-like › General secretion pathway protein M (EpsM) periplasmic domain-related › General secretion pathway protein M (EpsM) periplasmic domain-related › PilO | 0.55 | 42.0 | 3.90e-01 | 81.3% | 71.1% |
| 3503101 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.54 | 49.0 | 4.30e-01 | 98.1% | 87.1% |
| 4591679 | 5084.5.1.18 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Porin › BCSC_C | 0.54 | 48.0 | 3.37e-01 | 100.0% | 36.4% |
| 3453150 | 331.3.1.6 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › PRELI | 0.54 | 43.0 | 3.57e-01 | 95.3% | 47.7% |
| 5027995 | 331.4.1.0 ↗ | a+b two layers › TBP-like › Kinase associated domain 1, KA1 › Kinase associated domain 1, KA1 | 0.54 | 43.0 | 3.35e-01 | 86.0% | 59.0% |
| 3917010 | 243.3.1.20 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › AKAP28 | 0.53 | 49.0 | 4.62e-01 | 98.1% | 84.8% |
| 3881351 | 2484.1.1.39 ↗ | mixed a+b and a/b › Ribonuclease H-like › Ribonuclease H-like › Ribonuclease H-like › Fumble | 0.53 | 46.0 | 3.81e-01 | 92.5% | 97.2% |
| 5076771 | 512.1.1.2 ↗ | a+b two layers › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › PmbA_TldD_2nd | 0.53 | 44.0 | 4.44e-01 | 100.0% | 88.2% |
| 3740330 | 223.1.1.0 ↗ | a+b three layers › Profilin-like › sensor domains › sensor domains | 0.53 | 44.0 | 3.96e-01 | 94.4% | 74.2% |
| 3579468 | 71.1.1.21 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › PF25897 | 0.52 | 45.0 | 3.64e-01 | 99.1% | 83.0% |
| 4994610 | 512.1.1.2 ↗ | a+b two layers › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › PmbA_TldD_2nd | 0.52 | 43.0 | 4.20e-01 | 100.0% | 82.6% |
| 4666231 | 9.1.1.14 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › CpeS | 0.52 | 44.0 | 3.75e-01 | 96.3% | 56.6% |
| 5072530 | 512.1.1.2 ↗ | a+b two layers › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › PmbA_TldD_2nd | 0.51 | 43.0 | 4.07e-01 | 100.0% | 74.6% |
| 3973457 | 5084.8.1.1 ↗ | beta barrels › Outer membrane meander beta-barrels › Usher PapC translocation pore › Usher PapC translocation pore › Usher | 0.51 | 45.0 | 2.94e-01 | 100.0% | 22.4% |
| 4117439 | 512.1.1.2 ↗ | a+b two layers › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › a+b domain in putative modulator of DNA gyrase, PmbA/TldD (Pfam 01523) › PmbA_TldD_2nd | 0.51 | 35.0 | 3.53e-01 | 71.0% | 76.2% |